Literature DB >> 28291039

Performance Validity Testing in Neuropsychology: Scientific Basis and Clinical Application-A Brief Review.

Michael R Greher1, Thomas R Wodushek.   

Abstract

Performance validity testing refers to neuropsychologists' methodology for determining whether neuropsychological test performances completed in the course of an evaluation are valid (ie, the results of true neurocognitive function) or invalid (ie, overly impacted by the patient's effort/engagement in testing). This determination relies upon the use of either standalone tests designed for this sole purpose, or specific scores/indicators embedded within traditional neuropsychological measures that have demonstrated this utility. In response to a greater appreciation for the critical role that performance validity issues play in neuropsychological testing and the need to measure this variable to the best of our ability, the scientific base for performance validity testing has expanded greatly over the last 20 to 30 years. As such, the majority of current day neuropsychologists in the United States use a variety of measures for the purpose of performance validity testing as part of everyday forensic and clinical practice and address this issue directly in their evaluations. The following is the first article of a 2-part series that will address the evolution of performance validity testing in the field of neuropsychology, both in terms of the science as well as the clinical application of this measurement technique. The second article of this series will review performance validity tests in terms of methods for development of these measures, and maximizing of diagnostic accuracy.

Entities:  

Mesh:

Year:  2017        PMID: 28291039     DOI: 10.1097/PRA.0000000000000218

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  6 in total

1.  Patterns of Cognitive Test Scores and Symptom Complaints in Persons with TBI Who Failed Performance Validity Testing.

Authors:  Mark Sherer; Angelle M Sander; Jennie Ponsford; Leia Vos; Julia M P Poritz; Esther Ngan; Luis Leon Novelo
Journal:  J Int Neuropsychol Soc       Date:  2020-05-27       Impact factor: 2.892

Review 2.  Verbal memory measurement towards digital perspectives in first-episode psychosis: A review.

Authors:  Can Mişel Kilciksiz; Richard Keefe; James Benoit; Dost Öngür; John Torous
Journal:  Schizophr Res Cogn       Date:  2020-04-15

3.  Objective cognitive performance and subjective complaints in patients with chronic Q fever or Q fever fatigue syndrome.

Authors:  Daphne F M Reukers; Justine Aaronson; Joris A F van Loenhout; Birte Meyering; Koos van der Velden; Jeannine L A Hautvast; Cornelia H M van Jaarsveld; Roy P C Kessels
Journal:  BMC Infect Dis       Date:  2020-06-05       Impact factor: 3.090

4.  Salivary cortisol is associated with cognitive changes in patients with fibromyalgia.

Authors:  Yi-Ju Lin; Yu-Chieh Ko; Lok-Hi Chow; Fu-Jung Hsiao; Hung-Yu Liu; Pei-Ning Wang; Wei-Ta Chen
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

5.  Key challenges in neurocognitive assessment of individuals with antisocial personality disorder and psychopathy.

Authors:  Julia Griem; Nathan J Kolla; John Tully
Journal:  Front Behav Neurosci       Date:  2022-09-02       Impact factor: 3.617

6.  To adjust or not to adjust: Cut-off scores in performance validity testing in Portuguese older adults with dementia.

Authors:  Sandra Fernandes; Inês Ferreira; Luís Querido; Julia C Daugherty
Journal:  Front Psychol       Date:  2022-08-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.